1MAR
REFINED 1.8 ANGSTROMS STRUCTURE OF HUMAN ALDOSE REDUCTASE COMPLEXED WITH THE POTENT INHIBITOR ZOPOLRESTAT
Experimental procedure
| Spacegroup name | P 1 |
| Unit cell lengths | 47.640, 48.040, 40.480 |
| Unit cell angles | 64.47, 76.77, 76.07 |
Refinement procedure
| Resolution | 12.000 - 1.800 |
| R-factor | 0.18 |
| Rwork | 0.180 |
| RMSD bond length | 0.006 |
| RMSD bond angle | 1.650 |
| Phasing software | X-PLOR |
| Refinement software | X-PLOR |
Data quality characteristics
| Overall | |
| Low resolution limit [Å] | 20.000 * |
| High resolution limit [Å] | 1.800 * |
| Rmerge | 0.034 * |
| Total number of observations | 53037 * |
| Number of reflections | 26145 * |
| Completeness [%] | 90.4 * |
Crystallization Conditions
| crystal ID | method | pH | temperature | details |
| 1 | Vapor diffusion, hanging drop * | 5 * |
Crystallization Reagents in Literatures
| ID | crystal ID | solution | reagent name | concentration (unit) | details |
| 1 | 1 | drop | ALR2 | 7 (mg/ml) | |
| 2 | 1 | drop | zopolrestat | 0.2 (mM) | |
| 3 | 1 | drop | 2-mercaptoethanol | 3.5 (mM) | |
| 4 | 1 | drop | citrate | 25 (mM) | |
| 5 | 1 | reservoir | PEG6000 | 17 (%) | |
| 6 | 1 | reservoir | 2-mercaptoethanol | 7 (mM) | |
| 7 | 1 | reservoir | citrate | 50 (mM) |






